alexa Nanotechnology-based Drug Carriers and Cancer Therapy

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Nanotechnology-based Drug Carriers and Cancer Therapy

Nanotechnology-based therapeutics is an important tool in our armamentarium for improving efficacy and safety of cancer treatments. Key benefits from using nanotechnology-based therapeutics in cancer therapy accrue from improved drug solubility, stability, site-specificity and reduced multidrug resistance. Polymeric micelles, one of the several nanotechnology-based drug carriers, are an attractive and efficient approach to deliver poorly watersoluble anticancer drugs, improve drug stability and site-specificity leading to enhance therapeutic efficacy. The hydrophobic core functions as a repository for hydrophobic anticancer drugs. Stealth properties associated with the hydrophilic corona of polymeric micelles prevent opsonization by the reticuloendothelial system (RES) and hence reduces elimination of micelles from the bloodstream resulting in increased circulation times. Also, the small size ensures selective distribution to tumor cells via the enhanced permeability and retention (EPR) effect.

Source: Polycarbonate Micelles for Cancer Therapy


  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger